1. ATRT-35. SMARCB1-DEFICIENT TUMORS ACTIVATE BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES AND ARE SUSCEPTIBLE TO CHECKPOINT BLOCKADE AND TLR3 ACTIVATION. Issue 2 (22nd June 2018) Authors: Leruste, Amaury; Caudana, Pamela; Tauziede-Espariat, Arnault; Han, Zhi-Yan; Ramos, Rodrigo N; Nikolic, Jovan; Tosello, Jimena; Brohard, Solene; Andrianteranagna, Mamy; Chauvin, Céline; Masliah-Planchon, Julien; Sedlick, Christine; Coulomb, Aurore; Galmiche-Rolland, Louise; Ranchere, Dominique; Be... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATRT-35. SMARCB1-DEFICIENT TUMORS ACTIVATE BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES AND ARE SUSCEPTIBLE TO CHECKPOINT BLOCKADE AND TLR3 ACTIVATION. Issue 2 (22nd June 2018) Authors: Leruste, Amaury; Caudana, Pamela; Tauziede-Espariat, Arnault; Han, Zhi-Yan; Ramos, Rodrigo N; Nikolic, Jovan; Tosello, Jimena; Brohard, Solene; Andrianteranagna, Mamy; Chauvin, Céline; Masliah-Planchon, Julien; Sedlick, Christine; Coulomb, Aurore; Galmiche-Rolland, Louise; Ranchere, Dominique; Be... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗